IMIO raises $12m for freeze-dried ag biologicals targeting crop residues

· Agriculture & Food

Ag biologicals startup IMIO raised $12 million to develop a new generation of what it calls "dependable ag biologicals." According to CEO Charles Smith, the company's freeze-dried biologicals can deliver yield improvements along with fertilizer and tillage savings by unlocking nutrients trapped in crop residues. The raise places IMIO in the growing agtech segment focused on biological inputs, which farmers and investors have increasingly viewed as a way to cut synthetic fertilizer use and input costs. The funding gives the startup capital to advance its products toward broader use in row-crop farming.

Why it matters：Biological inputs are an expanding frontier for cutting fertilizer reliance, and funding rounds like this shape which agtech approaches reach mainstream row-crop farms.

Key points

  • IMIO raised $12 million.
  • Its freeze-dried biologicals target nutrients trapped in crop residues.
  • The company claims yield gains plus fertilizer and tillage savings.

Sources (original reporting)

More stories from this day